+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Age Related Macular Degeneration"

From
From
Cell and Gene Therapies in Ophthalmology - Product Thumbnail Image

Cell and Gene Therapies in Ophthalmology

  • Report
  • March 2024
  • 44 Pages
  • Global
From
From
Rapid Ophthalmology. Edition No. 1 - Product Thumbnail Image

Rapid Ophthalmology. Edition No. 1

  • Book
  • September 2013
  • 152 Pages
Ocular Aging. Impact on the Eye - Product Thumbnail Image

Ocular Aging. Impact on the Eye

  • Book
  • June 2025
Nanotechnology in Ophthalmology - Product Thumbnail Image

Nanotechnology in Ophthalmology

  • Book
  • July 2023
The Retina and its Disorders - Product Thumbnail Image

The Retina and its Disorders

  • Book
  • April 2011
Loading Indicator

Age-related Macular Degeneration (AMD) is a degenerative eye condition that affects the macula, the part of the eye responsible for central vision. It is the leading cause of vision loss in people over the age of 50. AMD is a major concern for the optical industry, as it can lead to severe vision impairment and blindness. Optical companies are developing treatments and technologies to help diagnose and manage AMD. These include optical coherence tomography (OCT) imaging, which can detect early signs of AMD, and anti-VEGF drugs, which can slow the progression of the disease. Additionally, companies are developing new lenses and other optical devices to help improve vision in those with AMD. Companies in the AMD market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more